MALIGNANT PLEURAL EFFUSION

This adverse event was reported 1688 times

These drugs are most commonly taken by patients reporting MALIGNANT PLEURAL EFFUSION:

# Drug Count
0 CARBOPLATIN 132
1 PEMBROLIZUMAB 116
2 BEVACIZUMAB 112
3 LETROZOLE 93
4 FUROSEMIDE 90
5 FULVESTRANT 88
6 PACLITAXEL 88
7 CYCLOPHOSPHAMIDE 77
8 CYCLOPHOSPHAMIDE FOR INJECTION 77
9 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 77
See all common drugs associated with MALIGNANT PLEURAL EFFUSION

MALIGNANT PLEURAL EFFUSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAZEMETOSTAT 14 0.0086
1 GEFITINIB 30 0.0033
2 ERLOTINIB HYDROCHLORIDE 40 0.0032
3 FULVESTRANT 88 0.0026
4 AFATINIB 16 0.0024
5 EXEMESTANE 51 0.0024
6 PEMETREXED DISODIUM 72 0.0018
7 OSIMERTINIB 60 0.0018
8 BENDAMUSTINE HYDROCHLORIDE 14 0.0016
9 ERGOCALCIFEROL 47 0.0016
See all drugs enriched for association with MALIGNANT PLEURAL EFFUSION